UnitedHealth Group Inc

UnitedHealth Group Inc(UNH)股票分析

$395.620

+18.713 (+4.73%)收盘时

Loading chart…
最高
396.440
开盘
382.290
成交量加权均价
391.45
成交量
7.77M
市值
447.71B
最低
382.290
成交额
3.04B
企业价值/息税折旧摊销前利润(TTM)
10.46

UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.

AI 分析 of UnitedHealth Group Inc (UNH)

买入

UnitedHealth Group is a good buy right now due to its solid fundamentals and positive market sentiment. The current price is $379.30, with a forward P/E ratio of 16.58, suggesting it is reasonably valued for future earnings growth. Additionally, analysts project earnings growth of over 13% annually in the next three to five years, which supports a bullish outlook. However, insider selling has surged by 2854.33% recently, indicating potential concerns about management confidence.

分析师评级(22)

上行空间 +0.56%
买入
22 买入
0 持有
0 卖出
当前: 395.62
最低
330.00
平均
397.82
最高
444.00

TD Cowen

2026-10-09

目标价

$402

买入

Piper Sandler

2026-10-09

目标价

$14

增持

Erste Group

2026-08-27

目标价

—

持有

Mizuho

2026-07-21

目标价

$493

跑赢大盘

Wells Fargo

2026-07-20

目标价

$526

增持

估值指标

UnitedHealth Group Inc(UNH)当前预期市盈率为 16.58,5 年平均预期市盈率为 20.64。

预期市盈率

低估
5 年均值 P/E
20.64
当前P/E
16.58
高估
23.92
低估
17.35

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
14.56
当前EV/EBITDA
10.46
高估
19.96
低估
9.16

预期市销率

低估
5 年均值 P/S
1.09
当前P/S
0.74
高估
1.39
低估
0.80

Alphio AI 对 UNH 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%UNH

$396.89

情景价格

基

基准

基准 · 50%UNH

$339.20

情景价格

悲

悲观

悲观 · 25%UNH

$315.88

情景价格

持有 UNH 的大户

C

Corient Private Wealth LP

+ 持有UNH

+51.17%

3个月收益率

T

Turtle Creek Management, LLC

+ 持有UNH

+21.39%

3个月收益率

M

MUFG Securities EMEA plc

+ 持有UNH

+13.36%

3个月收益率

W

W1M Investment Management Limited

+ 持有UNH

+13.24%

3个月收益率

A

Allen Holding Inc.

+ 持有UNH

+13.12%

3个月收益率

C

Compound Global Advisors, LLC

+ 持有UNH

+11.66%

3个月收益率

事件时间线

2026-10-14 (ET)

10:00:00

UnitedHealth and Others See Notable Gains

2026-10-13 (ET)

16:30:00

S&P 500 Earnings Expected to Grow 30% in Q3

12:30:00

S&P 500 Earnings Expected to Grow 30% in Q3

09:00:00

U.S. Stock Futures Mixed as Semiconductor Stocks Plunge

08:30:00

UnitedHealth Group Revises FY26 Guidance to 75% Star Plans

资讯

UNH 常见问题 —— 由 Alphio AI 解答

UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).

UnitedHealth Group is a good buy right now due to its solid fundamentals and positive market sentiment. The current price is $379.30, with a forward P/E ratio of 16.58, suggesting it is reasonably valued for future earnings growth. Additionally, analysts project earnings growth of over 13% annually in the next three to five years, which supports a bullish outlook. However, insider selling has surged by 2854.33% recently, indicating potential concerns about management confidence.

22 analysts cover UNH: 22 rate it Buy, 0 Hold and 0 Sell. The average price target is 397.82.

$UNH I look at this and remember, we're right back where we were one year ago 😂😂😂 @gpaisa @lextrading @JFDI @ArtOfTrends

展开
注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易